Your browser doesn't support javascript.
loading
Hospital volume and beyond first-line palliative systemic treatment in metastatic oesophagogastric adenocarcinoma: A population-based study.
Dijksterhuis, Willemieke P M; Verhoeven, Rob H A; Pape, Marieke; Slingerland, Marije; Haj Mohammad, Nadia; de Vos-Geelen, Judith; Beerepoot, Laurens V; van Voorthuizen, Theo; Creemers, Geert-Jan; Lemmens, Valery E P P; van Oijen, Martijn G H; van Laarhoven, Hanneke W M.
Afiliación
  • Dijksterhuis WPM; Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, the Netherlands.
  • Verhoeven RHA; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, the Netherlands.
  • Pape M; Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, the Netherlands.
  • Slingerland M; Department of Medical Oncology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, the Netherlands.
  • Haj Mohammad N; Department of Medical Oncology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht University, Utrecht, the Netherlands.
  • de Vos-Geelen J; Department of Internal Medicine, Division of Medical Oncology, GROW-School for Oncology and Developmental Biology, Maastricht UMC+, P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.
  • Beerepoot LV; Department of Medical Oncology, Elisabeth-TweeSteden Hospital, PO Box 90151, 5000 LC, Tilburg, the Netherlands.
  • van Voorthuizen T; Department of Medical Oncology, Rijnstate Hospital, Wagnerlaan 55, 6815 AD, Arnhem, the Netherlands.
  • Creemers GJ; Department of Medical Oncology, Catharina Hospital, Michelangelolaan 2, 5623 EFJ, Eindhoven, the Netherlands.
  • Lemmens VEPP; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, the Netherlands; Department of Public Health, Erasmus MC University Medical Centre, Doctor Molewaterplein 40, 3015 GD, Rotterdam, the Netherlands.
  • van Oijen MGH; Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), PO Box 19079, 3501 DB, Utrecht, the Netherlands.
  • van Laarhoven HWM; Amsterdam UMC, University of Amsterdam, Department of Medical Oncology, Cancer Center Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, the Netherlands. Electronic address: h.vanlaarhoven@amsterdamumc.nl.
Eur J Cancer ; 139: 107-118, 2020 11.
Article en En | MEDLINE | ID: mdl-32980749

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Unión Esofagogástrica / Hospitales de Alto Volumen / Hospitalización Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Unión Esofagogástrica / Hospitales de Alto Volumen / Hospitalización Límite: Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Eur J Cancer Año: 2020 Tipo del documento: Article País de afiliación: Países Bajos